Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 November 2006, Vol. 108, No. 10, pp. 3428-3433.
Prepublished online as a Blood First Edition Paper on August 3, 2006; DOI 10.1182/blood-2006-03-013821.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-03-013821v1
108/10/3428    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, L.
Right arrow Articles by Shipp, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, L.
Right arrow Articles by Shipp, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 30, 2006
Accepted July 10, 2006

Protein Tyrosine Phosphatase Receptor-Type O Truncated (PTPROt) Regulates SYK Phosphorylation, Proximal B-Cell Receptor Signaling and Cellular Proliferation

Linfeng Chen, Przemyslaw Juszczynski, Kunihiko Takeyama, Ricardo C.T. Aguiar, and Margaret A. Shipp*

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA

* Corresponding author; email: margaret_shipp{at}dfci.harvard.edu.

The strength and duration of B-cell receptor (BCR) signaling depends upon the balance between protein tyrosine kinase (PTK) activation and protein tyrosine phosphatase (PTP) inhibition. BCR-dependent activation of the SYK PTK initiates downstream signaling events and amplifies the original BCR signal. Although BCR-associated SYK phosphorylation is clearly regulated by PTPs, SYK has not been identified as a direct PTP substrate. Herein, we demonstrate that SYK is a major substrate of a tissue-specific and developmentally regulated PTP, PTPROt. PTPROt is a member of the PTPRO family (also designated GLEPP, PTP-{varphi}, PTP-oc and PTPu2), a group of highly conserved receptor-type PTPs that are thought to function as tumor suppressor genes. The overexpression of PTPROt inhibited BCR-triggered SYK tryosyl phosphorylation, activation of the associated adaptor proteins SHC and BLNK, and downstream signaling events including calcium mobilization and MAPK/ERK activation. PTPROt overexpression also inhibited lymphoma cell proliferation and induced apoptosis in the absence of BCR crosslinking, suggesting that the phosphatase modulates tonic BCR signaling.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020